| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
Divisions of
*
Rheumatology and Immunology and
Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261; Departments of
Immunology and Rheumatology,
Pharmacology, and
¶ Comparative Medicine, Merck Research Laboratories, Rahway, NJ 07065; and
|| Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge University, Cambridge, United Kingdom
At least 20 insulin-dependent diabetes (Idd) loci modify the progression of autoimmune diabetes in the NOD mouse, an animal model of human type 1 diabetes. The NOD.c3c4 congenic mouse, which has multiple B6- and B10-derived Idd-resistant alleles on chromosomes 3 and 4, respectively, is completely protected from autoimmune diabetes. We demonstrate in this study, however, that NOD.c3c4 mice develop a novel spontaneous and fatal autoimmune polycystic biliary tract disease, with lymphocytic peribiliary infiltrates and autoantibodies. Strains having a subset of the Idd-resistant alleles present in the NOD.c3c4 strain show component phenotypes of the liver disease: NOD mice with B6 resistance alleles only on chromosome 3 have lymphocytic liver infiltration without autoantibody formation, while NOD mice with B10 resistance alleles only on chromosome 4 show autoantibody formation without liver infiltration. The liver disease is transferable to naive NOD.c3c4 recipients using splenocytes from affected NOD.c3c4 mice, demonstrating an autoimmune etiology. Thus, substitution of non-NOD genetic intervals into the NOD strain can prevent diabetes, but in turn cause an entirely different autoimmune syndrome, a finding consistent with a generalized failure of self-tolerance in the NOD genetic background. The complex clinical phenotypes in human autoimmune conditions may be similarly resolved into largely overlapping biochemical pathways that are then modified, potentially by alleles at a few key chromosomal regions, to produce specific autoimmune syndromes.
This article has been cited by other articles:
|
|
 |
|
  D. L. Sim, H. Bagavant, Y. M. Scindia, Y. Ge, F. Gaskin, S. M. Fu, and U. S. Deshmukh Genetic Complementation Results in Augmented Autoantibody Responses to Lupus-Associated Antigens J. Immunol., September 1, 2009; 183(5): 3505 - 3511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Meagher, Q. Tang, B. T. Fife, H. Bour-Jordan, J. Wu, C. Pardoux, M. Bi, K. Melli, and J. A. Bluestone Spontaneous Development of a Pancreatic Exocrine Disease in CD28-Deficient NOD Mice J. Immunol., June 15, 2008; 180(12): 7793 - 7803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hunter, D. Rainbow, V. Plagnol, J. A. Todd, L. B. Peterson, and L. S. Wicker Interactions between Idd5.1/Ctla4 and Other Type 1 Diabetes Genes J. Immunol., December 15, 2007; 179(12): 8341 - 8349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lindor Ursodeoxycholic Acid for the Treatment of Primary Biliary Cirrhosis N. Engl. J. Med., October 11, 2007; 357(15): 1524 - 1529. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Irie, Y. Wu, K. Kachapati, R. S. Mittler, and W. M. Ridgway Modulating Protective and Pathogenic CD4+ Subsets via CD137 in Type 1 Diabetes Diabetes, January 1, 2007; 56(1): 186 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oertelt, Z.-X. Lian, C.-M. Cheng, Y.-H. Chuang, K. A. Padgett, X.-S. He, W. M. Ridgway, A. A. Ansari, R. L. Coppel, M. O. Li, et al. Anti-Mitochondrial Antibodies and Primary Biliary Cirrhosis in TGF-beta Receptor II Dominant-Negative Mice J. Immunol., August 1, 2006; 177(3): 1655 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Irie, Y. Wu, L. S. Wicker, D. Rainbow, M. A. Nalesnik, R. Hirsch, L. B. Peterson, P. S.C. Leung, C. Cheng, I. R. Mackay, et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis J. Exp. Med., May 15, 2006; 203(5): 1209 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, Y.-G. Chen, P. C. Reifsnyder, W. H. Schott, C.-H. Lee, M. Osborne, F. Scheuplein, F. Haag, F. Koch-Nolte, D. V. Serreze, et al. Targeted Disruption of CD38 Accelerates Autoimmune Diabetes in NOD/Lt Mice by Enhancing Autoimmunity in an ADP-Ribosyltransferase 2-Dependent Fashion. J. Immunol., April 15, 2006; 176(8): 4590 - 4599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shigihara, A. Shimada, Y. Oikawa, H. Yoneyama, Y. Kanazawa, Y. Okubo, K. Matsushima, E. Yamato, J.-i. Miyazaki, A. Kasuga, et al. CXCL10 DNA Vaccination Prevents Spontaneous Diabetes through Enhanced {beta} Cell Proliferation in NOD Mice J. Immunol., December 15, 2005; 175(12): 8401 - 8408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Faideau, E. Larger, F. Lepault, J. C. Carel, and C. Boitard Role of {beta}-Cells in Type 1 Diabetes Pathogenesis Diabetes, December 1, 2005; 54(suppl_2): S87 - S96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Jiang, M. S. Anderson, R. Bronson, D. Mathis, and C. Benoist Modifier loci condition autoimmunity provoked by Aire deficiency J. Exp. Med., September 19, 2005; 202(6): 805 - 815. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
